- maintained global health & global HRQL
- improved deterioration-free survival because early impairments in specific aspects of #HRQOL were insufficient to outweigh benefits of delayed clinical progression
@ANZUPtrials #ENZAMET #ESMO19 5/5
- associated with #DFS benefits at 3 yrs, smaller with
early docetaxel than without it, but differences not beyond the play of chance
#ESMO19 #HRQOL #PCSM 6/5
- to testosterone suppression alone is appropriate option for men with mHSPC starting testosterone suppression alone #ESMO19 #HRQOL 7/5